Over 20 years, continuous efforts have been undertaken to develop a therapeutic vaccine for chronic hepatitis B to enhance the virus-specific immune responses and overcome persistent HBV infection [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] .